KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Amortizatization of Intangibles: 2018

Historic Amortizatization of Intangibles for BeOne Medicines (ONC) over the last 1 years, with Dec 2018 value amounting to -$8.0 million.

  • BeOne Medicines' Amortizatization of Intangibles rose 98.85% to -$51,000 in Q3 2019 from the same period last year, while for Sep 2019 it was -$7.3 million, marking a year-over-year change of. This contributed to the annual value of -$8.0 million for FY2018, which is N/A change from last year.
  • BeOne Medicines' Amortizatization of Intangibles amounted to -$8.0 million in FY2018.
  • BeOne Medicines' 5-year Amortizatization of Intangibles high stood at -$8.0 million for FY2018, and its period low was -$8.0 million during FY2018.
  • In the last 1 years, BeOne Medicines' Amortizatization of Intangibles had a median value of -$8.0 million in 2018 and averaged -$8.0 million.